You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 7,553,872

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,553,872

Title:	Compounds and compositions for delivering active agents
Abstract:	Carrier compounds and compositions therewith which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
Inventor(s):	Sarubbi; Donald J. (Hartsdale, NY), Barantsevitch; Evgueni (Scarsdale, NY)
Assignee:	Emisphere Technologies, Inc. (Tarrytown, NY)
Application Number:	11/354,045
Patent Claims:	1. A composition comprising: (A) at least one active agent selected from human growth hormone, interferon, heparin, low molecular weight heparin, parathyroid hormone, and combinations thereof; and (B) the compound represented by the formula ##STR00022## or a salt thereof. 2. The composition of claim 1 wherein said active agent is human growth hormone. 3. The composition of claim 1 wherein said active agent is interferon. 4. The composition of claim 1 wherein said active agent is heparin. 5. The composition of claim 1 wherein said active agent is low molecular weight heparin. 6. The composition of claim 1 wherein said active agent is parathyroid hormone. 7. A dosage unit form comprising (A) a composition as defined in claim 1 and (B) (a) an excipient, (b) a diluent, (c) a disintegrant, (d) a lubricant, (e) a plasticizer, (f) a colorant, (g) a dosing vehicle, or (h) any combination thereof. 8. The dosage unit form of claim 7 comprising a tablet, a capsule, or a liquid. 9. The dosage unit form of claim 7 wherein said dosing vehicle is selected from the group consisting of water, 1,2-propane diol, ethanol, or any combination thereof. 10. The dosage unit form of claim 7 wherein said active agent is human growth hormone. 11. The dosage unit form of claim 7 wherein said active agent is interferon. 12. The dosage unit form of claim 7 wherein said active agent is heparin. 13. The dosage unit form of claim 7, wherein said active agent is low molecular weight heparin. 14. The dosage unit form of claim 7 wherein said active agent is parathyroid hormone. 15. A method for administering an active agent to an animal in need of said agent, said method comprising administering orally to said animal the composition of claim 1. 16. The method of claim 15 wherein said active agent is human growth hormone. 17. The method of claim 15 wherein said active agent is interferon. 18. The method of claim 15 wherein said active agent is heparin. 19. The method of claim 15 wherein said active agent is low molecular weight heparin. 20. The method of claim 15 wherein said active agent is parathyroid hormone.

Details for Patent 7,553,872

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015	⤷ Try a Trial	2017-02-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.